These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 5150076)
1. Early coronary atherosclerosis in primary type V hyperlipoproteinemia. Steiner G; Adelman AG; Silver MD Can Med Assoc J; 1971 Dec; 105(11):1172-4. PubMed ID: 5150076 [No Abstract] [Full Text] [Related]
2. Autopsy findings in type 3 hyperlipoproteinemia. Holimon JL; Wasserman AJ Arch Pathol; 1971 Dec; 92(6):415-7. PubMed ID: 5121031 [No Abstract] [Full Text] [Related]
3. [Arteriosclerosis and plasma lipoprotein--lipoprotein abnormalities and sclerotic cardiovascular diseases in patients with mental disorders]. Wada M; Tsuji H; Minamizono T; Komoda M; Nakaoka H Saishin Igaku; 1970 Oct; 25(10):2197-207. PubMed ID: 5482573 [No Abstract] [Full Text] [Related]
4. [Lipoprotein lipase and post-heparin esterase activity in primary type IV and V hyperlipoproteinemia]. Kucerová L; Fabian E; Fabianová J Cas Lek Cesk; 1974 Apr; 113(17):519-22. PubMed ID: 4451922 [No Abstract] [Full Text] [Related]
5. [The clinical significance of the risk factor hyperlipoproteinemia. Study on 2700 patients]. Dabels J; Rinke E Z Gesamte Inn Med; 1977 Jul; 32(13):194-6. PubMed ID: 930179 [TBL] [Abstract][Full Text] [Related]
7. Heparin-released blood plasma lipoprotein lipase activity in patients with hyperlipoproteinemia. Boberg J Acta Med Scand; 1972; 191(1-2):97-102. PubMed ID: 5032444 [No Abstract] [Full Text] [Related]
8. [Clinical study on the relationship between diabetes, hyperlipoproteinemia and atheromatosis]. Righetti A; Scherrer JR; Micheli H; Pometta D Schweiz Med Wochenschr; 1973 May; 103(18):668-73. PubMed ID: 4702987 [No Abstract] [Full Text] [Related]
9. [Hyperlipoproteinemia. A risk factor in peripheral-arterial and coronary occlusive disease]. Schwartzkopff W; Thonig S; Sorge F; Hoffmann H; Krüger B; Diehl HJ; Sonderkamp H Arzneimittelforschung; 1972 Oct; 22(10):1811-5. PubMed ID: 4678570 [No Abstract] [Full Text] [Related]
11. [Hyperlipoproteinemia (Frederickson's classification) in patients with myocardial infarction and imminent infarction]. Kedra M; Poleszak J; Rymar B Pol Tyg Lek; 1975 Jun; 30(22):945-7. PubMed ID: 1135069 [No Abstract] [Full Text] [Related]
12. [Ischemic heart disease and hyperlipoproteinemia]. Voslárová Z; Kucerová L; Papezová R Cas Lek Cesk; 1973 Oct; 112(43):1325-30. PubMed ID: 4753745 [No Abstract] [Full Text] [Related]
13. Lipoproteins and atherosclerosis in children: an early marriage? Strong JP; Zieske AW; Malcom GT Nutr Metab Cardiovasc Dis; 2001 Oct; 11 Suppl 5():16-22. PubMed ID: 12063771 [TBL] [Abstract][Full Text] [Related]
14. [Classification of hyperlipoproteinaemia in primary gout]. Mertz DP; Schwoerer P; Babucke G Dtsch Med Wochenschr; 1972 Apr; 97(15):600-4. PubMed ID: 5026795 [No Abstract] [Full Text] [Related]
15. [Incidence of hyperlipoproteinemia in coronary heart disease]. Noya M; Del Rio A; De Oya JC Rev Clin Esp; 1973 Aug; 130(3):237-42. PubMed ID: 4751034 [No Abstract] [Full Text] [Related]
16. Analysis of lipid disturbances in patients with angiographically confirmed coronary artery disease. Válek J; Grafnetter D; Fabián J; Belán A Nutr Metab; 1974; 16(4):193-202. PubMed ID: 4837726 [No Abstract] [Full Text] [Related]
17. Rationale for use of lipid-lowering drugs. Dayton S Fed Proc; 1971; 30(3):849-56. PubMed ID: 5575297 [No Abstract] [Full Text] [Related]
19. [Incidence of hyperlipoproteinemia in patients with past myocardial infarct]. Ciświcka-Sznajderman M; Mlyński J; Lotholc J Pol Tyg Lek; 1972 Oct; 27(43):1673-6. PubMed ID: 4639620 [No Abstract] [Full Text] [Related]
20. Dietary management of hyperlipoproteinemia. Levy RI; Bonnell M; Ernst ND J Am Diet Assoc; 1971 May; 58(5):406-16. PubMed ID: 5574141 [No Abstract] [Full Text] [Related] [Next] [New Search]